New Contracts.New Listing ... Taking PC Portability to Another Level

. . . New Contracts. New Listing. WPCS International (Nasdaq: WPCS), an engineering company that focuses on the implementation requirements of wireless technology and specialty communications systems, was awarded approximately $3.3 million in new contracts for its wireless services. New contracts include projects for U.S. Cellular, Nextel, T-Mobile, New Jersey State Police, Taj Mahal Casino-Hotel, General Electric and Lockheed Martin.The company, which had been trading on the OTC Bulletin Board, was recently approved for listing on the NASDAQ Small Cap Market.

. . . Taking PC portability to another level. You're traveling, but don't have your laptop with you. Wouldn't it be convenient to go to a cyber café and pull up and work on a copy of your PC with your Outlook Express, data files and internet favorites. And when you're done, no trace of your information is left behind and all changes will be automatically synchronized on your main PC. Now you can, using a DiskOnKey(R) device, a technology made possible by an agreement between M-Systems (NASDAQ:FLSH), a developer of USB flash drives, and PowerHouse Technologies Group (OTCBB:PWHT), a provider of mobile computing software.

Fromn: www.SmallcapRecap.com

Promising Arthritis Treatment...360-Degree Surveillance

. . . Promising arthritis treatment - EntreMed (Nasdaq: ENMD) announced preclinical data that showed promising results for 2ME2 in the treatment of rheumatoid arthritis. Oral treatment with 2ME2 resulted in a dose-dependent decrease in the severity of arthritic disease. A decrease in clinical symptoms with 2ME2 administration was accompanied by a marked inhibition of tissue and joint damage that are hallmarks of rheumatoid arthritis. EntreMed is currently evaluating 2ME2 formulations (Panzem® Capsules and Panzem® NCD) in Phase I and II clinical oncology studies, as well as preclinical studies of 2ME2 in inflammatory diseases such as rheumatoid arthritis.

From: www.InvestingIN.com/biotech

. . . 360-degree surveillance - IPIX (NASDAQ:IPIX), a supplier of 360-degree, immersive imaging cameras and technologies is teaming with new video surveillance partners to provide more panoramic threat detection. Recent partnerships include surveillance software manufacturers VistaScape Security Systems and ObjectVideo. IPIX's immersive imaging technology provides security personnel with a more complete, real-time view of a security area, offers a greater level of functionality and reduces the number of necessary cameras, infrastructure and installation costs.

From: www.InvestingIN.com/security

Editing Genes...Preclinical Promise

. . . Editing Genes - It seems that the some of the human genome's "errors" may soon be able to be corrected with new gene editing technology. Sangamo BioSciences (Nasdaq: SGMO) has announced the results of a study demonstrating that its zinc finger DNA-binding protein technology achieved "highly efficient, permanent correction of a disease-causing gene in primary human cells." ZFN Technology facilitated the modification of a DNA sequence at the site of a mutation in the gene. The study also indicated that gene correction was permanent.

. . . Preclinical Promise - Pre-clinical data demonstrated that Tarvacin(TM) from Peregrine Pharmaceuticals (Nasdaq: PPHM), and related Anti-Phospholipid Therapy agents, have anti-viral therapy which may have far reaching implications for the treatment of infectious disease. According to Dr. Philip Thorpe, professor of pharmacology at UT Southwestern, "since Tarvacin(TM) targets a basic, universal property of enveloped viruses that is host-derived and independent of the viral genome, it may be effective against a broad spectrum of enveloped viruses."

From: www.InvestingIN.com/biotech